Serum corticosteroid-binding globulin, cortisol, and nonprotein-bound cortisol levels in patients receiving estrogen for carcinoma of the prostate.
D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D000311:Adrenal Glands / Q000503:physiopathology; D001667:Binding, Competitive; D001797:Blood Protein Electrophoresis; D002247:Carbon Isotopes; D002986:Clinical Trials as Topic; D004054:Diethylstilbestrol / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007030:Hypothalamo-Hypophyseal System; D008297:Male; D008797:Metyrapone; D010902:Pituitary Gland / Q000503:physiopathology; D010913:Pituitary-Adrenal System; D010919:Placebos; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D012709:Serum Albumin / Q000032:analysis; D013268:Stimulation, Chemical; D013997:Time Factors; D014156:Transcortin; D014316:Tritium
D002247:Carbon Isotopes; D010919:Placebos; D012709:Serum Albumin; D014316:Tritium; D004054:Diethylstilbestrol; D014156:Transcortin; D006854:Hydrocortisone; D008797:Metyrapone